Catalyst Wire Dossier Catalyst Wire Dossier

VRC-HIVMAB060-00-AB (VRC01)

VRC01 · National Institute of Allergy and Infectious Diseases (NIAID)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VRC-HIVMAB060-00-AB (VRC01), covering 2017-10-31 to 2017-10-31. Get the full timeline:

Most recent: Clinical Trial Update: VRC-HIVMAB060-00-AB (VRC01) in People With Chronic HIV Infection Undergoing Analytical Treatment Interruption [Phase 1]

See pricing